Idecabtagene Vicleucel (Ide-Cel, Bb2121), a BCMA-directed CAR T-cell Therapy: Qualitative Analyses of Pretreatment Patient Interviews in the KarMMa Trial.
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2020)